Management of patients with intermediate stage hepatocellular carcinoma

Hepatocellular carcinoma (HCC) causes a significant health burden globally and its impact is expected to increase in the coming years. Intermediate stage HCC, as defined by the Barcelona Clinic Liver Cancer (BCLC) system stage B, represents up to 30% of patients at diagnosis and encompasses a broad...

Descripción completa

Detalles Bibliográficos
Autores principales: Prince, David, Liu, Ken, Xu, Weiqi, Chen, Minjiang, Sun, Jin-Yu, Lu, Xiao-Jie, Ji, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649909/
https://www.ncbi.nlm.nih.gov/pubmed/33224278
http://dx.doi.org/10.1177/1758835920970840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649909/
https://www.ncbi.nlm.nih.gov/pubmed/33224278
http://dx.doi.org/10.1177/1758835920970840

Ejemplares similares